World's Largest Resource for Cardiovascular Perfusion
The HEMOCHRON® instruments(Models 401 and 801)are portable, battery operated instruments designed toperform an array of whole blood coagulation tests at any patient location.
We conclude that central venous pressure could be a valuable predictor of short-term outcome in patients with cirrhosis undergoing cardiac surgery. The model for end-stage liver disease score is the best predictor of cirrhotic patients who are at high risk for cardiac surgery.
We recommend identification and treatment of hyperinflammation using existing, approved therapies with proven safety profiles to address the immediate need to reduce the rising mortality.